Survival benefits of adding simvastatin to standard therapy for secondary prevention of bleeding esophageal varices in patients with hepatitis C-related liver cirrhosis

Survival benefits of adding simvastatin to standard therapy for secondary prevention of bleeding esophageal varices in patients with hepatitis C-related liver cirrhosis

Abstract Background The combination of endoscopic band ligation and beta-blockers is the standard of care treatment for secondary prevention of variceal bleeding; however, rebleeding still occurs with associated high mortality. Simvastatin (a lipid-lowering agent) was found to reduce portal hyperten...

Full description

Bibliographic Details
Main Authors: Helmy Elshazly, Hasan Zaghlah, El-Sayed Tharwa, Ahmed Abuamer, Dina Nor-Eldin, Reem El Sheemy, Mohamed El Kassas
Format: Article
Language:English
Published: SpringerOpen 2021-09-01
Series:Egyptian Liver Journal
Subjects:
Bleeding varices
Beta-blockers
Egypt
Hematemesis
Cirrhosis
Secondary prevention
Online Access:https://doi.org/10.1186/s43066-021-00143-2

Internet

https://doi.org/10.1186/s43066-021-00143-2

Similar Items